Patent details

EP4214240 Title: ANTI-CCR8 ANTIBODIES

Basic Information

Publication number:
EP4214240
PCT Application Number:
US2022074214
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227547528
PCT Publication Number:
WO2023010054
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CCR8 ANTIBODIES
French Title of Invention:
ANTICORPS ANTI-CCR8
German Title of Invention:
ANTI-CCR8 ANTIKÖRPER
SPC Number:

Dates

Filing date:
27/07/2022
Grant date:
09/10/2024
EP Publication Date:
26/07/2023
PCT Publication Date:
02/02/2023
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/10/2024
EP B1 Publication Date:
09/10/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/07/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/10/2024
 
 

Name:
AbbVie Inc.
Address:
1 N. Waukegan Road, North Chicago, IL 60064, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
23/10/2024
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
SCHMIDT PAUSTIAN, Amanda, M.
Address:
United States (US)

2

Name:
SEAGAL, Jane
Address:
United States (US)

3

Name:
MCCLUSKEY, Andrew, J.
Address:
United States (US)

4

Name:
WILSBACHER, Julie, L.
Address:
United States (US)

Priority

Priority Number:
202163226118 P
Priority Date:
27/07/2021
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202441
Publication date:
09/10/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
4
Annual Fee Amount:
41 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
23/10/2024 Power Of Attorney 1
24/10/2024 Outgoing Correspondence 1